17.61
-0.28
(-1.57%)
At close: January 31 at 4:00:01 PM EST
18.00
+0.39
+(2.21%)
After hours: 7:56:20 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
1,304,600.00
1,268,800.00
1,581,600.00
717,400.00
Total Liabilities Net Minority Interest
644,600.00
703,900.00
799,900.00
75,200.00
Total Equity Gross Minority Interest
660,000.00
564,900.00
781,700.00
642,200.00
Total Capitalization
660,800.00
565,900.00
782,700.00
644,200.00
Common Stock Equity
660,000.00
564,900.00
781,700.00
642,200.00
Capital Lease Obligations
2,400.00
4,500.00
4,000.00
2,100.00
Net Tangible Assets
660,000.00
564,900.00
781,700.00
642,200.00
Working Capital
1,023,100.00
945,100.00
1,290,800.00
653,900.00
Invested Capital
660,800.00
565,900.00
782,700.00
644,200.00
Tangible Book Value
660,000.00
564,900.00
781,700.00
642,200.00
Total Debt
3,200.00
5,500.00
5,000.00
4,100.00
Share Issued
68,000.00
53,200.00
52,871.65
48,455.74
Ordinary Shares Number
68,000.00
53,200.00
52,871.65
48,455.74
12/31/2020 - 9/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYMR Kymera Therapeutics, Inc.
39.59
-2.13%
ZNTL Zentalis Pharmaceuticals, Inc.
1.7400
+4.82%
PRAX Praxis Precision Medicines, Inc.
76.55
+0.46%
RVMD Revolution Medicines, Inc.
42.95
-0.28%
KURA Kura Oncology, Inc.
7.91
-1.49%
FDMT 4D Molecular Therapeutics, Inc.
5.60
0.00%
BBIO BridgeBio Pharma, Inc.
34.21
-4.89%
CGEM Cullinan Therapeutics, Inc.
10.56
-3.83%
NRIX Nurix Therapeutics, Inc.
19.71
-1.52%
APLS Apellis Pharmaceuticals, Inc.
29.01
-4.54%